Why the study?
Does health insurance type and antihypertensive medication use improve effective coverage of hypertension treatment in middle-aged and older Chinese adults?
Does health insurance type and antihypertensive medication use improve effective coverage of hypertension treatment in middle-aged and older Chinese adults?
Effective coverage for hypertension treatment in China remains low (22.4%), highlighting a significant gap between medication use and actual blood pressure control, which is heavily influenced by the type of health insurance.
Effective coverage lags treatment rates and varies by insurance; leaves open whether scheme reforms can improve control.
METHODS: We used the baseline survey and first follow-up surveys of the China Health and Retirement Longitudinal Study of middle-aged and older populations conducted between 2011 and 2013. Correlates of effective coverage and treatment coverage for hypertension were analysed using multivariate logistic regression models, after controlling for demographic characteristics. RESULTS: In 2011, 38.40% of 13 702 individuals surveyed were identified with hypertension. Overall, the effective treatment coverage among the middle-aged and older population in China from 2011 to 2013 was only 22.40% compared to the treatment coverage of 55.86%. Variations in effective coverage among patients enrolled in the three public health insurance schemes ranged from 22.60% to 29.31%. CONCLUSIONS: The level of effective coverage for hypertension treatment in China was still very low, and that health insurance schemes play a significant role in improving treatment coverage and effective coverage for hypertension treatment. In the implementation of China's health system reform, health equity and health care equality should be emphasised and enhanced by offering more equitable benefits packages across social health insurance schemes.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: